Ask any biotech professional about Stanley Cohen and Herbert Boyer and they will tell you about their incredible contributions to modern biotechnology.
But what about Roland Tibbetts?
My guess is there are more than a few quizzical looks out there.
So who is Roland Tibbetts?
In many ways, Roland Tibbetts did for the commercialization of biotechnology, what Cohen and Boyer did for the science.
He is the creator of the Small Business Innovation Research (SBIR) program. (Now you can stump your colleagues with that new bit of trivia.)
Mr. Tibbetts developed a pilot program in the 1970s when he worked at the National Science Foundation and that initiative has grown into today’s SBIR program. (At BIO, we recently worked to successfully secure a long-term reauthorization of this important program.)
As you know, the SBIR program has been a vital tool for helping bolster research and development and the commercialization of scientific discoveries across our industry.
Just ask Amgen, Genzyme, and Biogen Idec. Each of these companies used the SBIR program when they were starting out—and today they have grown to become industry leaders.
So who are the biotech leaders of tomorrow?
Come check out the new Innovation Zone at the 2014 BIO International Convention (June 23-26), where we will be featuring early-stage biotech companies that received Small Business Innovation Research/Small Business Technology Transfer (SBIR/STTR) grants from the National Institutes of Health and National Science Foundation.
It is just one of the exciting new programming features of our revamped 2014 International Convention.